Literature DB >> 22573613

N-terminal acetylation of α-synuclein induces increased transient helical propensity and decreased aggregation rates in the intrinsically disordered monomer.

Lijuan Kang1, Gina M Moriarty, Lucy A Woods, Alison E Ashcroft, Sheena E Radford, Jean Baum.   

Abstract

The conformational properties of soluble α-synuclein, the primary protein found in patients with Parkinson's disease, are thought to play a key role in the structural transition to amyloid fibrils. In this work, we report that recombinant 100% N-terminal acetylated α-synuclein purified under mild physiological conditions presents as a primarily monomeric protein, and that the N-terminal acetyl group affects the transient secondary structure and fibril assembly rates of the protein. Residue-specific NMR chemical shift analysis indicates substantial increase in transient helical propensity in the first 9 N-terminal residues, as well as smaller long-range changes in residues 28-31, 43-46, and 50-66: regions in which the three familial mutations currently known to be causative of early onset disease are found. In addition, we show that the N-terminal acetylated protein forms fibrils that are morphologically similar to those formed from nonacetylated α-synuclein, but that their growth rates are slower. Our results highlight that N-terminal acetylation does not form significant numbers of dimers, tetramers, or higher molecular weight species, but does alter the conformational distributions of monomeric α-synuclein species in regions known to be important in metal binding, in association with membranes, and in regions known to affect fibril formation rates.
Copyright © 2012 The Protein Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22573613      PMCID: PMC3403430          DOI: 10.1002/pro.2088

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  40 in total

1.  The E46K mutation in alpha-synuclein increases amyloid fibril formation.

Authors:  Eric A Greenbaum; Charles L Graves; Amanda J Mishizen-Eberz; Michael A Lupoli; David R Lynch; S Walter Englander; Paul H Axelsen; Benoit I Giasson
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

Review 2.  Helix capping.

Authors:  R Aurora; G D Rose
Journal:  Protein Sci       Date:  1998-01       Impact factor: 6.725

3.  alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.

Authors:  M G Spillantini; R A Crowther; R Jakes; M Hasegawa; M Goedert
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

4.  Structural characterization of copper(II) binding to alpha-synuclein: Insights into the bioinorganic chemistry of Parkinson's disease.

Authors:  Rodolfo M Rasia; Carlos W Bertoncini; Derek Marsh; Wolfgang Hoyer; Dmitry Cherny; Markus Zweckstetter; Christian Griesinger; Thomas M Jovin; Claudio O Fernández
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-14       Impact factor: 11.205

5.  NMR mapping of copper binding sites in alpha-synuclein.

Authors:  Yoon-Hui Sung; Carla Rospigliosi; David Eliezer
Journal:  Biochim Biophys Acta       Date:  2005-11-28

6.  Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

Authors:  M Baba; S Nakajo; P H Tu; T Tomita; K Nakaya; V M Lee; J Q Trojanowski; T Iwatsubo
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

7.  Sensitivity of secondary structure propensities to sequence differences between alpha- and gamma-synuclein: implications for fibrillation.

Authors:  Joseph A Marsh; Vinay K Singh; Zongchao Jia; Julie D Forman-Kay
Journal:  Protein Sci       Date:  2006-11-06       Impact factor: 6.725

8.  Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease.

Authors:  John P Anderson; Donald E Walker; Jason M Goldstein; Rian de Laat; Kelly Banducci; Russell J Caccavello; Robin Barbour; Jiping Huang; Kristin Kling; Michael Lee; Linnea Diep; Pamela S Keim; Xiaofeng Shen; Tim Chataway; Michael G Schlossmacher; Peter Seubert; Dale Schenk; Sukanto Sinha; Wei Ping Gai; Tamie J Chilcote
Journal:  J Biol Chem       Date:  2006-07-17       Impact factor: 5.157

9.  Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.

Authors:  K A Conway; J D Harper; P T Lansbury
Journal:  Nat Med       Date:  1998-11       Impact factor: 53.440

10.  Residual structure, backbone dynamics, and interactions within the synuclein family.

Authors:  Yoon-Hui Sung; David Eliezer
Journal:  J Mol Biol       Date:  2007-07-17       Impact factor: 5.469

View more
  77 in total

1.  A pH-dependent switch promotes β-synuclein fibril formation via glutamate residues.

Authors:  Gina M Moriarty; Michael P Olson; Tamr B Atieh; Maria K Janowska; Sagar D Khare; Jean Baum
Journal:  J Biol Chem       Date:  2017-07-14       Impact factor: 5.157

2.  N-terminal acetylation stabilizes N-terminal helicity in lipid- and micelle-bound α-synuclein and increases its affinity for physiological membranes.

Authors:  Igor Dikiy; David Eliezer
Journal:  J Biol Chem       Date:  2013-12-12       Impact factor: 5.157

3.  N-Terminal Acetylation Affects α-Synuclein Fibril Polymorphism.

Authors:  Matthew D Watson; Jennifer C Lee
Journal:  Biochemistry       Date:  2019-08-21       Impact factor: 3.162

4.  Hydrogen exchange of disordered proteins in Escherichia coli.

Authors:  Austin E Smith; Larry Z Zhou; Gary J Pielak
Journal:  Protein Sci       Date:  2015-03-02       Impact factor: 6.725

Review 5.  Cell Biology and Pathophysiology of α-Synuclein.

Authors:  Jacqueline Burré; Manu Sharma; Thomas C Südhof
Journal:  Cold Spring Harb Perspect Med       Date:  2018-03-01       Impact factor: 6.915

Review 6.  To be disordered or not to be disordered: is that still a question for proteins in the cell?

Authors:  Kris Pauwels; Pierre Lebrun; Peter Tompa
Journal:  Cell Mol Life Sci       Date:  2017-06-13       Impact factor: 9.261

7.  Membrane remodeling by α-synuclein and effects on amyloid formation.

Authors:  Zhiping Jiang; Michel de Messieres; Jennifer C Lee
Journal:  J Am Chem Soc       Date:  2013-10-17       Impact factor: 15.419

Review 8.  Exploring the accessible conformations of N-terminal acetylated α-synuclein.

Authors:  Gina M Moriarty; Maria K Janowska; Lijuan Kang; Jean Baum
Journal:  FEBS Lett       Date:  2013-03-13       Impact factor: 4.124

9.  Role of Parkinson's Disease-Linked Mutations and N-Terminal Acetylation on the Oligomerization of α-Synuclein Induced by 3,4-Dihydroxyphenylacetaldehyde.

Authors:  Vanderlei de Araújo Lima; Lucas Alex do Nascimento; David Eliezer; Cristian Follmer
Journal:  ACS Chem Neurosci       Date:  2018-11-05       Impact factor: 4.418

Review 10.  Alpha-synuclein and intracellular trafficking: impact on the spreading of Parkinson's disease pathology.

Authors:  Sibylle E Eisbach; Tiago F Outeiro
Journal:  J Mol Med (Berl)       Date:  2013-04-25       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.